Indegene Limited has formally announced its Q4 and Annual FY26 earnings conference call through an official communication to stock exchanges on April 22, 2026. The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing stakeholders with an opportunity to engage with senior management regarding the company's financial performance.

Earnings Call Schedule and Details

The earnings conference call has been scheduled for Thursday, April 30, 2026, at 8:00 AM IST. This timing allows both domestic and international investors to participate in the discussion regarding Indegene's quarterly and annual financial results.

Management Participation

The earnings call will feature key members of Indegene's senior leadership team who will present the financial results and address investor queries. The company has confirmed participation from top executives to ensure comprehensive coverage of business performance and strategic initiatives.

Access Information for Participants

Indegene has provided multiple access options for participants to join the earnings conference call. The company has established universal access numbers and offers early registration through DiamondPass for enhanced convenience.

Regulatory Compliance

The earnings call announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Srishti Ramesh Kaushik signed the official communication on April 22, 2026. The company has noted that the announced schedule remains subject to changes, if any, and will keep stakeholders informed of any modifications.

Indegene Limited has filed its quarterly compliance certificate under SEBI regulations for the quarter ended March 31, 2026. The company submitted the mandatory certificate as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming adherence to dematerialization compliance requirements.

Regulatory Compliance Filing

The certificate, dated April 09, 2026, was signed by Company Secretary and Compliance Officer Srishti Ramesh Kaushik. The filing confirms that all details of securities dematerialized during the quarter have been properly furnished to both BSE Limited and National Stock Exchange of India Limited, where the company's shares are listed.

RTA Confirmation

MUFG Intime India Private Limited, serving as the company's registrar and transfer agent, provided supporting confirmation dated April 6, 2026. The RTA confirmed that all securities received from depository participants for dematerialization during the quarter were processed and confirmed to the depositories within prescribed timelines.

Key confirmations from the RTA include:

• Securities received for dematerialization were properly confirmed or rejected to depositories
• All security certificates were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners
• All processes were completed within prescribed regulatory timelines

Dematerialization Activity

The RTA specifically noted that no requests for rematerialization were received during the quarter ended March 31, 2026. This indicates that all securities transactions during the period involved dematerialization processes only, with no conversion back to physical certificate form.

Corporate Information

Indegene Limited operates from its registered office at Manyata Embassy Business Park in Bengaluru, Karnataka. The company maintains its listing on both BSE Limited under scrip code 544172 and National Stock Exchange under the trading symbol INDGN. This quarterly filing represents part of the company's ongoing regulatory compliance obligations as a publicly listed entity in the Indian capital markets.